Want to see JP:6368 full AI Analyst Report?

Organo Corp. (6368) Price & Analysis

1 Followers

6368 Stock Chart & Stats

¥15140.00

¥170.00(1.97%)

At close: Jan 08 4:00 PM EST

¥15140.00

¥170.00(1.97%)

Day’s Range― - ―

52-Week Range¥8,720.00 - ¥20,145.00

Previous CloseN/A

Volume316.80K

Average Volume (3M)305.77K

Market Cap

¥739.96B

Enterprise Value¥825.74B

Total Cash (Recent Filing)¥20.57B

Total Debt (Recent Filing)¥28.15B

Price to Earnings (P/E)25.4

Beta1.65

Next Earnings

Aug 04, 2026

EPS Estimate

126

Next Dividend Ex-DateN/A

Dividend Yield1.43%

Share Statistics

EPS (TTM)546.36

Shares Outstanding46,359,700

10 Day Avg. Volume290,510

30 Day Avg. Volume305,770

Financial Highlights & Ratios

PEG Ratio1.25

Price to Book (P/B)4.38

Price to Sales (P/S)3.52

P/FCF Ratio21.30

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)677.61

Revenue Forecast (FY)¥202.48B

Bulls Say, Bears Say

Bulls Say

Revenue & Margin ExpansionSustained multi-year revenue growth together with substantial gross- and net-margin expansion indicates structural improvements in pricing, product mix, and cost control. These durable profitability gains support reinvestment capacity and resilience to cyclical pressure over a multi-quarter horizon.

Strong Recent Cash GenerationHigh operating and free cash flow in 2026, with FCF nearly matching net income, reflects quality of earnings and strong cash conversion. Durable cash generation underpins capital spending, deleveraging, and shareholder returns if sustained across business cycles.

Healthy Capital StructureModerate leverage and rising equity provide financial flexibility and a buffer against shocks. A conservative debt-to-equity ratio supports investment and M&A optionality while keeping refinancing and interest risks manageable in the medium term.

Bears Say

Rising Absolute DebtAn uptick in borrowings raises sensitivity to future cash flow and earnings consistency; if higher debt funds working capital or expansion, the company must sustain operating cash to avoid leverage creep. Persistent increases would erode balance sheet resilience over time.

Volatile Historical Cash FlowPast episodes of negative operating and free cash flow highlight execution and working-capital timing risks. Even with recent improvement, recurring volatility could impair investment planning and debt servicing if adverse cycles recur, making consistency a key monitorable.

Moderating Revenue GrowthA slowdown in top-line momentum suggests the business may be entering a maturing phase or facing tougher comps. Slower revenue expansion limits margin leverage and places greater emphasis on cost efficiency and new product or market initiatives to sustain long-term earnings growth.

Organo Corp. News

Organo Corporation Transfers Shares to Enhance Indonesian Water Treatment Venture

An announcement from Organo Corp. ( ($JP:6368) ) is now available. Organo Corporation announced its decision to transfer...

1y ago

6368

6368 FAQ

What was Organo Corp.’s price range in the past 12 months?

Organo Corp. lowest stock price was ¥8720.00 and its highest was ¥20145.00 in the past 12 months.

What is Organo Corp.’s market cap?

Organo Corp.’s market cap is ¥739.96B.

When is Organo Corp.’s upcoming earnings report date?

Organo Corp.’s upcoming earnings report date is Aug 04, 2026 which is in 31 days.

How were Organo Corp.’s earnings last quarter?

Organo Corp. released its earnings results on May 13, 2026. The company reported ¥226.23 earnings per share for the quarter, beating the consensus estimate of ¥189.28 by ¥36.95.

Is Organo Corp. overvalued?

According to Wall Street analysts Organo Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Organo Corp. pay dividends?

Organo Corp. pays a Semiannually dividend of ¥110 which represents an annual dividend yield of 1.43%. See more information on Organo Corp. dividends here

What is Organo Corp.’s EPS estimate?

Organo Corp.’s EPS estimate is 126.

How many shares outstanding does Organo Corp. have?

Organo Corp. has 46,359,700 shares outstanding.

What happened to Organo Corp.’s price movement after its last earnings report?

Organo Corp. reported an EPS of ¥226.23 in its last earnings report, beating expectations of ¥189.28. Following the earnings report the stock price went up 1.83%.

Which hedge fund is a major shareholder of Organo Corp.?

Currently, no hedge funds are holding shares in JP:6368

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Organo Corp.

Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured into two main divisions: the Water Treatment Engineering Business Unit and the Performance Products Business Unit. It offers a comprehensive portfolio of water purification solutions, encompassing various pure water systems such as reverse osmosis (RO), regenerative (automatic and manual), electric regeneration, desktop, cabinet, electrode ionization high-purity, cartridge, and two-stage RO systems. Additionally, Organo supplies ultrapure water systems, available in desktop and cabinet models, alongside final polishing units. The company's equipment range extends to include alkaline electrolyzed water production machinery, homogenizers, electro conductivity and resistivity meters, and ion exchange filters. Beyond physical systems, Organo Corporation provides specialized chemicals for water, wastewater, and RO treatment. Its extensive selection of industrial filters covers micro, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon filters. Commercial water purifiers are also part of its product offering. Organo's expertise is applied across numerous industries: delivering ultrapure and multi-functional water production, wastewater treatment, valuable resource recovery, and organic solvent refining systems for the electronics sector; constructing water supply and sewage treatment facilities; supplying purified water, UF water, and water for injection production and supply systems, coupled with consulting services, for the pharmaceutical industry; providing critical solutions for power generation, including condensate filters, demineralizers, reactor and fuel pool cleanup, makeup water, and waste water treatment systems; and implementing sugar refining systems and associated equipment.